Esco Lifesciences installed an Esco Isoclean Healthcare Platform Isolator at a Thai hospital for the preparation of chemotherapy drugs
Newly-installed Isoclean Healthcare Platform Isolator
Esco Lifesciences installed an Esco Isoclean Healthcare Platform Isolator (HPI) on March 2021 at the Amnat Charoen Hospital in Amnat Charoen, Thailand.
The HPI unit replaces the hospital's previous isolator and is the first Esco product to be installed in the hospital.
The interior is constructed with pharmaceutical-grade SS316L
The installed HPI unit is a two-glove isolator intended for the preparation of chemotherapy drugs for cancer patients. Since these drugs are hazardous, the isolator is negatively pressured to protect the operator and environment in case of a breach in the system.
To ensure leak tightness, the unit is certified as a Class 2 containment enclosure in accordance with ISO 10648-2. It provides HEPA-filtered, unidirectional airflow that creates an ISO Class 5 environment inside the work zone to provide a sterile/aseptic environment. The interior is constructed with pharmaceutical-grade SS316L with large radius corners for easier cleaning. The unit is also equipped with two pass through chambers (PTC) that have electromagnetic interlocking doors with time delay effect to ensure safety and containment between the PTCs and the main process chamber.
The HPI unit was donated by the Rotary Club of Amnat Charoen and the Rotary Club of Silom, which are part of Rotary International District 3340 and 3350, respectively. With this donation, Amnat Charoen hospital, a government hospital in the capital district of the Amnat Charoen province in eastern Thailand, can better serve the needs of its community, particularly cancer patients undergoing chemotherapy treatment, and Esco Lifesciences is proud to have been part of this endeavor.